Nr 546 addiction medication Study guides, Study notes & Summaries

Midterm Exam: NR546/ NR 546 Psychopharmacology for the Psychiatric-Mental Health Nurse Practitioner | Questions and Verified Answers| New!! 2023/ 2024 Update– Chamberlain Q: Is nicotine an inducer or an inhibitor of the CYP 1A2 enzyme? Answer: inducer Q: Nicotine is an inducer of the CYP 1A2 enzyme. Does the PMHNP anticipate Joshua may need a higher or lower dose of olanzapine to achieve a therapeutic response? Answer: Higher -Nicotine is an inducer of the CYP 1A2 enzym...

Chamberlain NR 546 Week 6 Addiction Medication Table

NR 546 Week 6 Addiction Medications Table | Latest 2023/2024. Maintenance treatment of opioid dependence  Induction of treatment for opioid dependence (Bunavail only) Half-life: Buprenorphine: 24–42 hours Naloxone: 2–12 hours Metabolism: CYP 450 3A4 Notable Side Effects:  Headache, constipation, nausea  Oral hypoesthesia, glossodynia  Orthostatic hypotension  Implant specific: insertion site pain, Initial Dosing Considerations:  Patients must be in a m...

Midterm Exam: NR546 / NR 546 (Latest Update 2024 / 2025) Advanced Pharmacology Psychopharmacology for the Psychiatric-Mental Health Nurse Practitioner Review | Complete Guide with Questions and Verified Answers | 100% Correct - Chamberlain Q: when could the client's cognitive status create an ethical issue Answer: if the client is unable to self determine care or is a danger to self or others Q: informed consent Answer: client has the right to receive enough information to make decisions about ...

NR 546 Week 6 Addiction Medication Table QUESTIONS AND CORRECT DETAILED ANSWERS WITH RATIONALES (VERIFIED ANSWERS) |ALREADY GRADED A+

NR 546 Week 6 Addiction Medication Table QUESTIONS AND CORRECT DETAILED ANSWERS WITH RATIONALES (VERIFIED ANSWERS) |ALREADY GRADED A+

NR 546 Week 6 Addiction Medication Table QUESTIONS AND CORRECT DETAILED ANSWERS WITH RATIONALES (VERIFIED ANSWERS) |ALREADY GRADED A+

NR 546 Week 6 Addiction Medication Table QUESTIONS AND CORRECT DETAILED ANSWERS WITH RATIONALES (VERIFIED ANSWERS) |ALREADY GRADED A+ Drug Name Indication Neurotransmitter(s) Affected Target Symptoms Half-life (T1/2), Metabolism (CYP 450 enzyme) Notable Side Effects (link to NT or affected brain circuit) Initial Dosing Considerations Specific lifespan considerations (age, pregnancy, breastfeeding) Buprenorphine (Subutex) Indication: • Maintenance treatment of opioid dep...

NR 546 Week Addiction Medications Table. Drug Name Indication (Bold is FDA approved) Neurotransmitter(s) Affected Target Symptoms Half-life (T1/2), Metabolism (CYP 450 enzyme) Notable Side Effects (link to NT or affected brain circuit) Initial Dosing Considerations Specific lifespan considerations (age, pregnancy, breastfeeding) Buprenorphine (Subutex) Indication:  Maintenance treatment of opioid dependence (sublingual)  Maintenance treatment of opioid dependence in pat...